ORASURE TECHNOLOGIES, INC Federal Income Tax Expense (Benefit), Continuing Operations
ORASURE TECHNOLOGIES, INC (OSUR) reported Federal Income Tax Expense (Benefit), Continuing Operations of $3.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Expense Statement › Income Tax
us-gaap:FederalIncomeTaxExpenseBenefitContinuingOperations · last filed 2026-08-07
- ORASURE TECHNOLOGIES, INC federal income tax expense (benefit), continuing operations for the quarter ending 2026-06-30 was $3.00K, a 98.09% decline year-over-year.
- ORASURE TECHNOLOGIES, INC federal income tax expense (benefit), continuing operations for the quarter ending 2026-03-31 was $3.00K, a 62.50% decline year-over-year.
- ORASURE TECHNOLOGIES, INC federal income tax expense (benefit), continuing operations for the quarter ending 2025-12-31 was $32.00K, a 84.00% decline year-over-year.
- ORASURE TECHNOLOGIES, INC federal income tax expense (benefit), continuing operations for the quarter ending 2025-09-30 was $3.00K.
- ORASURE TECHNOLOGIES, INC federal income tax expense (benefit), continuing operations for fiscal 2025 was $200.00K, a 0.00% change from fiscal 2024.
- ORASURE TECHNOLOGIES, INC federal income tax expense (benefit), continuing operations for fiscal 2024 was $200.00K.
- ORASURE TECHNOLOGIES, INC federal income tax expense (benefit), continuing operations for fiscal 2023 was $0.00.
| Period end | Federal Income Tax Expense (Benefit), Continuing Operations 3 month | Federal Income Tax Expense (Benefit), Continuing Operations 6 month | Federal Income Tax Expense (Benefit), Continuing Operations 9 month | Federal Income Tax Expense (Benefit), Continuing Operations 12 month |
|---|---|---|---|---|
| 2026-06-30 | $3.00K 10-Q · filed 2026-08-07 | $7.00K 10-Q · filed 2026-08-07 | $38.00K derived: sum of 3 quarters · filed 2026-08-07 | $41.00K derived: sum of 4 quarters · filed 2026-08-07 |
| 2026-03-31 | $3.00K 10-Q · filed 2026-05-08 | $35.00K derived: sum of 2 quarters · filed 2026-05-08 | $38.00K derived: sum of 3 quarters · filed 2026-05-08 | $195.00K derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-12-31 | $32.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-09 | $35.00K derived: sum of 2 quarters · filed 2026-03-09 | $192.00K derived: sum of 3 quarters · filed 2026-08-07 | $200.00K 10-K · filed 2026-03-09 |
| 2025-09-30 | $3.00K 10-Q · filed 2025-11-05 | $160.00K derived: sum of 2 quarters · filed 2026-08-07 | $168.00K 10-Q · filed 2025-11-05 | $368.00K derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-06-30 | $157.00K 10-Q · filed 2026-08-07 | $165.00K 10-Q · filed 2026-08-07 | $365.00K derived: sum of 3 quarters · filed 2026-08-07 | $365.00K derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-03-31 | $8.00K 10-Q · filed 2026-05-08 | $208.00K derived: sum of 2 quarters · filed 2026-05-08 | $208.00K derived: sum of 3 quarters · filed 2026-05-08 | $208.00K derived: sum of 4 quarters · filed 2026-05-08 |
| 2024-12-31 | $200.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-09 | $200.00K derived: sum of 2 quarters · filed 2026-03-09 | $200.00K derived: sum of 3 quarters · filed 2026-03-09 | $200.00K 10-K · filed 2026-03-09 |
| 2024-09-30 | $0.00 10-Q · filed 2025-11-05 | $0.00 derived: sum of 2 quarters · filed 2025-11-05 | $0.00 10-Q · filed 2025-11-05 | |
| 2024-06-30 | $0.00 10-Q · filed 2025-08-06 | $0.00 10-Q · filed 2025-08-06 | ||
| 2024-03-31 | $0.00 10-Q · filed 2025-05-07 | |||
| 2023-12-31 | $0.00 10-K · filed 2026-03-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| PRO DEX INC (PDEX) | United States | $0.234B | 13.64 |
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |